๐ก๐๐ช ๐๐ข๐ฃ๐ ๐๐ก ๐ง๐๐ ๐๐๐๐๐ง ๐๐๐๐๐ก๐ฆ๐ง ๐๐๐ก๐๐๐ฅ – ๐ ๐๐๐ข๐ฅ ๐๐ฅ๐๐๐๐ง๐๐ฅ๐ข๐จ๐๐๐ฆ ๐๐ก ๐ง๐๐ ๐๐๐ฅ๐ฆ๐ง ๐๐๐๐ ๐ข๐ ๐ฎ๐ฌ๐ฎ๐ฒ
During the first half of 2026 , several important advances were made in cancer treatment. However, it is important to distinguish between entirely new drugs , expanded approvals for existing therapies , and promising clinical trial results . There was no universal breakthrough that cures all cancers , but several new therapies were approved, and existing treatments were significantly expanded. Area Development Significance Breast Cancer New approvals for Trodelvy and Datroway Improved treatment options, particularly for triple-negative breast cancer. Prostate Cancer Expanded approval for Truqap Personalized treatment for patients with PTEN mutations. Kidney Cancer Combination of Welireg and Keytruda Reduces the risk of cancer recurrence after surgery. Bladder Cancer New combination therapy with Imfinzi Improved treatment for high-risk bladder cancer. Leukemia New oral combination therapy Makes treatment easier for older patients with acute myeloid leukemia (AML). Most Promising Devel...